Delivery Order SPE2DB22D3501-SPE2DB25FXJ97
- Not listed
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $87,331.76 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitive award, issued without set-aside provisions, is structured as a firm fixed-price delivery order under a larger indefinite delivery contract. The awardee, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $14,800.80 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract specifies...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,247.80 by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. This competitively awarded, firm fixed-price delivery order is unset-aside and has an ultimate completion date of September 9, 2025. The contract represents a child order issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order valued at $10,389.40 by the Defense Logistics Agency's Medical Supply Chain on September 26, 2025, with an ultimate completion date of September 29, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement running through December 2026. The delivery order will...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $41,480.40 to AmerisourceBergen Drug Corp on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $27,768.48 to AmerisourceBergen Drug Corp on July 9, 2025, with an ultimate completion date of July 10, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The work will be performed at...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical products valued at $12,336.54 under a firm fixed-price contract with an ultimate completion date of September 24, 2025. This is a competitive, non-set-aside award to the vendor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $14,651.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on September 1, 2025, with completion targeted for September 2, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. AmerisourceBergen, a major pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $4,575.90 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle. The award was made through open competition with no set-aside...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXJ97Delivery Order
The Defense Logistics Agency (DLA) awarded a $14,244.70 delivery order to AmerisourceBergen Drug Corp for SOTRADECOL 1% Vial 2ML pharmaceutical products, with an ultimate completion date of September 18, 2025. This is a firm fixed price, non-set-aside contract with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a child delivery order under a larger indefinite delivery contract (IDC) vehicle with DLA. This delivery order falls under AmerisourceBergen's broader $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which operates through December 2026 and serves as a comprehensive pharmaceutical supply mechanism for military healthcare programs. As a major pharmaceutical distributor and established federal vendor, AmerisourceBergen has demonstrated capability to deliver specialized pharmaceutical products and medical supplies competitively to support Defense Health Agency and other government healthcare systems globally. The company's federal contract portfolio reflects extensive experience supplying brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to meet military and veteran healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.2k | 9/17/25 |